AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05564507 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: TEE simulation-based training
Description: All participants of the TEE simulation-based training group received:~1. a traditional didactic training using e-learning with a national free-access online course;~2. two teaching sessions using a TEE simulator for 2 hours per session. The simulation session will involve standardized initial teaching of normal cardiac, including anatomy of mitral valve with some mitral regurgitation cases, aortic valve, tricuspid valve, interatrial septum, and left atrial appendage, and demonstration of image acquisition by the teacher (time duration: 30 min). The duration of each session was 2 h with a 6:1 student to instructor ratio. Each subject had a dedicated 20 min of hands-on to manipulate the probe and undertake a sequential TEE examination under the supervision of the teacher. Other participants could watch their colleagues working on the TEE simulator.
Study NCT04011891 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic Partial Nephrectomy
Description: Robotic partial nephrectomy using da Vinci robot.
Study NCT04011891 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Partial Nephrectomy
Description: Standard open partial nephrectomy
Study NCT03447587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Each subject will be treated with predefined acupoints including bilateral Ear-Shenmen, Touwei (ST8), Sishencong (EX-HN1), and unilateral Yintang (EXHN3) and Baihui (GV20) on the head (total 8 needles). Subject's current symptoms will be ascertained using a Traditional Chinese Medicine symptom checklist and eight additional acupoints will therefore be selected and needled based on their clinical judgements. The acupuncture treatment will consistent of two sessions per week (30 minutes) for 4 consecutive weeks.
Study NCT03447587 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham acupuncture
Description: Subjects will be treated at 1 cm posteriorly and laterally adjacent to the same acupoints as the traditional acupuncture group using validated non-invasive sham needles. Subjects will also be assessed with Traditional Chinese Medicine checklist. The acupuncturist, setting, treatment frequency, and duration of the treatment course will be the same as in the traditional acupuncture group.
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Plain rice with plain water
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cumin Rice
Description: Cumin rice with plain water
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cumin Drink
Description: Cumin drink with plain rice
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cornsilk Rice (Low dose)
Description: Low dose cornsilk rice with plain water
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cornsilk Rice (High dose)
Description: High dose cornsilk rice with plain water
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cornsilk Drink (Low dose)
Description: Low dose cornsilk drink with plain rice
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cornsilk Drink (High dose)
Description: High dose cornsilk drink with plain rice
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tamarind Rice
Description: Tamarind rice with plain water
Study NCT03685916 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tamarind Drink
Description: Tamarind drink with plain rice
Study NCT01582776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide and GA101
Description: 1000mg of GA101 on D8, D15 and D22of cycle 1 and on D1 of cycles 2 to 6. Oral lenalidomide once daily at 10/15/20/25mg (phase I part) or at recommended dose (phase II part) on days 1 to 21 of a 28-day cycle for the first cycle and on days 2 to 22 of a 28-day cycle for cycles 2 to 6.
Study NCT04037280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Four type of exercises will be delivered to patients. These exercises differ for posology and typology.
Study NCT01715961 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: anthropometric measurement
Description: To attest the muscular strength: hand grip test, balance test, up and go test
Study NCT02143128 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Efficacy Safety Score
Description: Evaluation using the score for postoperative patients
Study NCT00794274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-100004
Description: After the screening period, subjects will receive CC-10004 20mg by mouth BID for 84 days. The 84-day duration of treatment is expected to provide adequate time to assess the short-term efficacy and safety of CC-10004 in a population of subjects with chronic cutaneous sarcoidosis.
Study NCT05085678 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Co'moon (online website to support women with AET)
Description: The tool contains three parts:~1. e-learning based on the brochure on adjuvant endocrine therapy (AET) in the University Hospital Leuven,~2. serious game where patients are confronted with scenes of their daily life and motivational guidelines to stimulate their self-management,~3. a patient-reported-outcome questionnaire (PROMs), reported in the patient medical file.~The tool is designed to stimulate patients self-management of their menopausal AET-related complaints and to discuss them with their health care professionals .
Study NCT02143128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Verbal Numeric Rating Scale
Description: Patients assessed for postoperative pain using VNRS (0-10)
Study NCT04135937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Smoking cessation pharmacotherapy prescribed in accordance with package insert.
Study NCT04135937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: Smoking cessation pharmacotherapy prescribed in accordance with package insert.
Study NCT04135937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: Behavioral intervention; modules include identifying reasons for quitting, setting a quit date, breathing relaxation technique, identifying smoking triggers, identifying social support, and education about relapse prevention
Study NCT04135937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy
Description: Participants may be prescribed single-formulation NRT (i.e., nicotine patch) or dual NRT (patch + rescue method such as nicotine gum, inhaler, or lozenges).
Study NCT04135937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention Text Messaging
Description: Participants will be invited to utilize SmokefreeVET, a mobile text messaging service for military Veterans trying to quit smoking. The 6- to 8-week program provides 24/7 encouragement, advice, and tips to help smokers quit smoking and stay quit.
Study NCT03428243 — intervention group
Intervention type: DEVICE
Intervention: truSculpt
Description: Device comparison of Circumference measurement at Baseline vs 18 months post treatment
Study NCT03205319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: e-learning
Description: The e-learning for patients is a user friendly, audiovisual based, online-accessible program, designed especially for this study. The e-learning will contain information on dyspepsia and advice on lifestyle interventions
Study NCT00256178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapaquistat acetate and simvastatin
Description: Lapaquistat acetate 50 mg, tablets, orally, once daily and stable simvastatin therapy for up to 24 weeks.
Study NCT00256178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapaquistat acetate and simvastatin
Description: Lapaquistat acetate 100 mg, tablets, orally, once daily and stable simvastatin therapy for up to 24 weeks.
Study NCT01545817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib followed by everolimus
Description: All patients received Pazopanib (800 mg once daily orally continuous dosing) until disease progression then second line everolimus (10 mg once daily orally continuous dosing)
Study NCT00256178 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Simvastatin
Description: Lapaquistat acetate placebo-matching tablets, orally, once daily and stable simvastatin therapy for up to 24 weeks.
Study NCT02291237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eleclazine
Description: Tablet (s) administered orally once daily
Study NCT02291237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match eleclazine administered orally once daily
Study NCT02026401 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NGM282
Study NCT03252522 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants
Description: 60% of participants will take 3-4 capsules of broad spectrum micronutrients three times per day for eight weeks. Following the initial 8 weeks (of the RCT), all participants will have the option to participate in an open label extension, during which time the child would take the active micronutrient treatment for 8 weeks
Study NCT03252522 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 40% of participants will take 3-4 capsules of inactive placebo three times per day for eight weeks.
Study NCT02383667 — intervention group
Intervention type: DEVICE
Intervention: Electrocardiogram holter
Study NCT02327429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Chinese menu plan for type 2 diabetes
Description: The intervention is a menu plan, recipes and tips on healthy eating delivered one-on-one between the participant and the facilitator. There will be 4 such one-on-one meetings. The goal is to facilitate behaviour change that results in a healthier diet.
Study NCT02492906 — intervention group
Intervention type: OTHER
Intervention: Osteoarthrosis
Description: Primary severe knee osteoarthrosis and chronic knee pain.
Study NCT02492906 — intervention group
Intervention type: OTHER
Intervention: Healthy
Description: Healthy and non-symptomatic volunteers.
Study NCT01345279 — intervention group
Intervention type: DRUG
Intervention: cisplatin
Description: 50 mg/m2 IV cisplatin on day 1 and then every 3 weeks for 6 courses
Study NCT01345279 — intervention group
Intervention type: DRUG
Intervention: topotecan
Description: topotecan 0.75 mg/m2 on days 1, 2, and 3. The regimen was repeated every 3 weeks for 6 courses
Study NCT01345279 — intervention group
Intervention type: DRUG
Intervention: paclitaxel
Description: 135 mg/m2 paclitaxel on day 1 and then every 3 weeks for 6 courses
Study NCT04249128 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vegetarian Collagen
Description: Collagen is a protein made up of amino-acids, which are in turn built of carbon, oxygen and hydrogen.
Study NCT06505473 — intervention group
Intervention type: BEHAVIORAL
Intervention: music-CBT
Description: notched relaxation music combined with personalized CBT
Study NCT05469776 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bicruciate-retaining total knee arthroplasty
Study NCT05469776 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: posterior-stabilized total knee arthroplasty
Study NCT04340570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication management via televisit to home
Description: Pharmacist led home based televisit for medication management
Study NCT03365869 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sirolimus
Description: Sirolimus or placebo were added to patients every day
Study NCT03365869 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sirolimus
Description: Sirolimus or placebo were added to patients every day
Study NCT03657576 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: C134
Description: C134 is a virus that was created from an oncolytic Herpes Simplex Virus (oHSV) known to infect and kill tumor cells. The Investigators have made changes to the original virus to make C134. It efficiently infects tumor cells (not normal healthy cells) and induces an immune response to fight the cancer as well.
Study NCT00608127 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LupusorbTM
Description: Single treatment
Study NCT04027634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin program
Description: This exercise program aimed to increase patient participation and control their BW through Baduanjin program. The entire program continued for 3 months (mid-September to mid-December 2014), and the intervention was performed for 60 min 3 times per week; particular attention was paid to the disease characteristics of the patients with chronic schizophrenia and to preventing excessive fatigue. Every session began with a 20-min warm-up, followed by 20 min of Baduanjin program, and ended with a cool-down session. The participants were instructed, with the assistance of a video, to practice Baduanjin program in a group by two authors who are experienced in the psychiatric nurses and had been trained in this program.
Study NCT03814213 — intervention group
Intervention type: OTHER
Intervention: CGA
Description: Multi-level Health assessment
Study NCT03814213 — intervention group
Intervention type: OTHER
Intervention: tailored care
Description: Tailored care based on problems identified by CGA
Study NCT02459470 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fluid loading
Description: fluid loading was performed by using 7ml/kg of 6% hydroxyethyl starch within 10 min to all patients
Study NCT02195271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Study NCT02195271 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin
Study NCT02431507 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnap
Description: This is a non-randomized clinical trial.Patients 21-70 years diagnosed with moderate to severe obstructive sleep apnea will have the Magnap Magnetic Apnea Device surgically implanted on the subject's hyoid bone and used in conjunction with an external neck brace and magnet to open airway during sleep in treatment of Obstructive Sleep Apnea. We will monitor for safety, brace compliance and improvement of symptoms of sleep apnea for a total of 13 months.
Study NCT02026401 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02999646 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MVX-ONCO-1
Description: Autologous cells: 1 vial containing 4x10\^6 irradiated tumor cells Capsules: 2 biocompatible capsules loaded with 8x10\^5 MVX-1 cells
Study NCT03788785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental arm
Description: The specific tobacco cessation intervention will be based on meeting with trained nurses : three 1/2 hour session of assessment of current addictive behaviors and motivation to change smoking habits occurring within five days tops.
Study NCT03788785 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control arm
Description: In the control arm, patients will receive the current standard of care for these patients, namely referral to external care after general advice on tobacco cessation (self-help tools).
Study NCT02402608 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: dietary supplement
Description: oral essential amino acid (EAA), whey protein and vitamin D mixture
Study NCT02402608 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo consisting of an equicaloric amount of maltodextrin with the same flavour and appearance as for the intervention product
Study NCT02088866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal Lidocaine
Description: The intervention will use 5% commercially available transdermal lidocaine in clinical practice for the treatment of tinnitus. This dose will be tailored to patient preference.
Study NCT02322866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sarecycline
Description: 1.5 mg/kg/day taken orally at the same time each day.
Study NCT02322866 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo-matching sarecycline tablets, taken orally at the same time each day.
Study NCT03094923 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training
Description: The inspiratory muscle training (IMT) will be carried out in the IG with Threshold® IMT (Respironics New Jersey, Inc) consisting of a unidirectional flow control valve which assures the constant resistance (linear load) between 7 and 41cmH20.~The IMT will be carried out in the sitting position with a load of 30% of the MIP during the two weeks preceding the surgery, seven days a week, twice daily in three series of ten repetitions with a 30 second interval between series, under the supervision of a physiotherapist. A load of 15% of the MIP was used only on the first day of training in order for the individual to adapt to the equipment. Subsequently, the 30% MIP load will be applied and readjusted according to the new MIP values determined every four days.
Study NCT05110118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY01008
Description: Single intravenous injection
Study NCT05110118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avastin
Description: Single intravenous injection
Study NCT02423746 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Check Up Behavioral Parenting Training Program (BPT)
Description: The Family Check Up is an evidence-based Behavioral Parenting Training (BPT) program focused on harnessing parents' motivation to change and skills training.~Intervention parents receive the initial assessment session followed by 3 Family Check-up Sessions within one month of baseline assessment followed by a post-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention.
Study NCT02423746 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Behavioral Placebo
Description: The Behavioral Placebo sessions will consist of presentations of information about healthy lifestyles.~Parents in the control group will receive an initial assessment session followed by three behavioral placebo sessions followed by a post-placebo-intervention assessment. All sessions will be delivered in the patients' usual hearing clinics and will last between 60 and 90 minutes. One month post-intervention, participants will complete post-test measures repeating baseline measures, plus acceptability ratings of intervention.
Study NCT04045054 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Link Team
Description: A VA home care Link Team (clinical pharmacist, social worker, physical activity trainer) provides the intervention based on a conceptual model of home care as a bridge between hospital and home, in which three interconnected domains determine short-term and long-term outcomes: medical complexity (e.g., medication management), social complexity (e.g., caregiving, environment), and functional impairment (e.g., mobility, physical activity). The Link Team provides support and assessment for each domain, and will use tablet technology and wearable sensors in the home to gather patient data and facilitate communication. At the end of formal home care services, the Link Team provides patient-centered care in: 1) support for the the Veteran and caregiver in the event of changes in medical condition or medications and social or caregiver stressors; and 2) coaching to the Veteran and the caregiver during this transition period to optimize functional mobility and physical activity.
Study NCT01763125 — intervention group
Intervention type: OTHER
Intervention: Blood collection
Description: Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.
Study NCT04494191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flibanserin 100Mg Tab
Description: One tablet contains 100 mg Flibanserin
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cladribine
Description: Given IV
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Given PO
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV
Study NCT02756572 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Filgrastim
Description: Given SC
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine Phosphate
Study NCT02756572 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: Undergo allogeneic hematopoietic stem cell transplantation
Study NCT02756572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given IV
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride
Description: Given IV
Study NCT02756572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Given PO
Study NCT02756572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies